Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy

AIMS: The goal of the study was to evaluate the efficacy of epalrestat, an aldose reductase inhibitor, on diabetic retinopathy and diabetic nephropathy, based on analysis of the results of the Aldose Reductase Inhibitor–Diabetes Complications Trial, a 3-year multicentre comparative clinical trial of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hotta, N, Kawamori, R, Fukuda, M, Shigeta, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533175/
https://www.ncbi.nlm.nih.gov/pubmed/22507139
http://dx.doi.org/10.1111/j.1464-5491.2012.03684.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533175/
https://www.ncbi.nlm.nih.gov/pubmed/22507139
http://dx.doi.org/10.1111/j.1464-5491.2012.03684.x

Ejemplares similares